[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334542-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334542-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","activity-of-potassium-channels-in-cd8-t-lymphocytes-diagnostic-and-prognostic-biomarker-in-ovarian-cancer","Activity of Potassium Channels in CD8+ T Lymphocytes: Diagnostic and Prognostic Biomarker in Ovarian Cancer?","","CD8+ T cells suppress tumor growth and support immunotherapy, with ion channels regulating Ca2+-dependent functions including cytokine/granzyme production and target killing. Kv1.3 and KCa3.1 help maintain a negative membrane potential to sustain Ca2+ influx through CRAC channels. The study evaluated Kv1.3, KCa3.1, and CRAC expression in CD8+ cells from ovarian cancer patients (n=7) and found distinct expression and activity patterns linked to malignant disease and elevated Ca2+ responses.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/activity-of-potassium-channels-in-cd8-t-lymphocytes-diagnostic-and-prognostic-biomarker-in-ovarian-cancer/334542/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/activity-of-potassium-channels-in-cd8-t-lymphocytes-diagnostic-and-prognostic-biomarker-in-ovarian-cancer/334542.png","ImageObject",300,407,{"name":42,"@type":43},"Patrick","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the biological role of CD8+ T cells in ovarian cancer?","Question",{"text":63,"@type":64},"CD8+ cytotoxic T cells recognize antigens through TCR/CD3 activation, then kill malignant cells via apoptosis and cytokine signaling to support anti-tumor immunity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which ion channels were assessed in CD8+ cells?",{"text":68,"@type":64},"The study assessed Kv1.3, KCa3.1, and CRAC (Ca2+ release-activated Ca2+ channel) in CD8+ cells from ovarian cancer patients.",{"name":70,"@type":61,"acceptedAnswer":71},"How did Kv1.3 and KCa3.1 differ between malignant and other groups?",{"text":72,"@type":64},"Kv1.3 expression was higher in patients with malignant tumors than in control or benign groups, while KCa3.1 activity was lower in the malignant tumor group compared with the others.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334542,1790183263,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":4},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","Communication  \nActivity of Potassium Channels in CD8+ T Lymphocytes: Diagnostic and Prognostic Biomarker in Ovarian Cancer?  \nVivien Jusztus 1, Ghofrane Medyouni 1, Adrienn Bagosi 1, Rudolf Lampé 2, György Panyi 1, Orsolya Matolay 2, Eszter Maka 2, Zoárd Tibor Krasznai 2, Orsolya Vörös 1,† and Péter Hajdu 1,3, *,†  \nCitation: Jusztus, V.; Medyouni, G.; Bagosi, A.; Lampé, R.; Panyi, G.; Matolay, O.; Maka, E.; Krasznai, Z.T.; Vörös, O.; Hajdu, P. Activity of Potassium Channels in CD8+ T Lymphocytes: Diagnostic and Prognostic Biomarker in Ovarian Cancer? Int. J. Mol. Sci. 2024, 25, 1949 . [https://doi.org/10.3390/ijms25041949](https://doi.org/10.3390/ijms25041949)  \nAcademic Editor: Lars Kaestner  \nReceived: 30 November 2023  \nRevised: 31 January 2024  \nAccepted: 3 February 2024  \nPublished: 6 February 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Egyetem tér 1., H-4032 Debrecen, Hungary; [jusztus.vivien@med.unideb.hu](jusztus.vivien@med.unideb.hu) (V.J.);  \n[medyouni.ghofrane@med.unideb.hu](medyouni.ghofrane@med.unideb.hu) (G.M.); [bagosiadri@gmail.com](bagosiadri@gmail.com) (A.B.); [panyi@med.unideb.hu](panyi@med.unideb.hu) (G.P.); [orsolyavoros89@gmail.com](orsolyavoros89@gmail.com) (O.V.)  \n2 Department of Gynecology and Obstetrics, Faculty of Medicine, University of Debrecen, Egyetem tér 1., H-4032 Debrecen, Hungary; [lampe.rudolf@med.unideb.hu](lampe.rudolf@med.unideb.hu) (R.L.); [orsolya.matolay@med.unideb.hu](orsolya.matolay@med.unideb.hu) (O.M.); [maka.eszter@med.unideb.hu](maka.eszter@med.unideb.hu) (E.M.); [krasznai.zoard@med.unideb.hu](krasznai.zoard@med.unideb.hu) (Z.T.K.)  \n3 Division of Dental Biochemistry, Department of Basic Medical Sciences, Faculty of Dentistry, University of Debrecen, Egyetem tér 1., H-4032 Debrecen, Hungary  \n* [Correspondence: hajdup@med.unideb.hu](Correspondence: hajdup@med.unideb.hu); Tel.: +36-52-411-600-66611 † These authors contributed equally to this work.  \nAbstract: CD8+ T cells play a role in the suppression of tumor growth and immunotherapy. Ion channels control the Ca2+-dependent function of CD8+ lymphocytes such as cytokine/granzyme production and tumor killing. Kv1.3 and KCa3.1 K+ channels stabilize the negative membrane potential of T cells to maintain Ca2+ influx through CRAC channels. We assessed the expression of Kv1.3, KCa3.1 and CRAC in CD8+ cells from ovarian cancer (OC) patients (n = 7) . We found that the expression level of Kv1.3 was higher in patients with malignant tumors than in control or benign tumor groups while the KCa3.1 activity was lower in the malignant tumor group as compared to the others. We demonstrated that the Ca2+ response in malignant tumor patients is higher compared to control groups. We propose that altered Kv1.3 and KCa3.1 expression in CD8+ cells in OC could bea reporter and may serve as a biomarker in diagnostics and that increased Ca2+ response through CRAC may contribute to the impaired CD8+ function.  \nKeywords: ovarian cancer; tumor immunology; ion channel; CD8 lymphocytes; CRAC channel; potassium channel  \n1. Introduction  \nOvarian cancer (OC) is a common gynecological malignancy, which affects many women in the world. The incidence of OC is high, and it has a limited, \u003C50%, 5-year survival rate [1](incidence: 3.4% out of all cases for women and 22.5% for all gynecological cancers; source: [https://gco.iarc.fr/](https://gco.iarc.fr/) (accessed on 24 January 2024)). The detection of OCis problematic at the early stage; patients with OC are diagnosed in an advanced period of disease (stage III–IV), and by then, the cancer has generated m","cbCaimqw5wSvPKRf","https://ap.wps.com/l/cbCaimqw5wSvPKRf","pdf",1083823,"English","# Introduction\n## Ovarian cancer burden and biomarkers\n## Tumor immunology and CD8+ activation\n## Ion channels and Ca2+ signaling in CD8+ function","[{\"question\":\"What is the biological role of CD8+ T cells in ovarian cancer?\",\"answer\":\"CD8+ cytotoxic T cells recognize antigens through TCR/CD3 activation, then kill malignant cells via apoptosis and cytokine signaling to support anti-tumor immunity.\"},{\"question\":\"Which ion channels were assessed in CD8+ cells?\",\"answer\":\"The study assessed Kv1.3, KCa3.1, and CRAC (Ca2+ release-activated Ca2+ channel) in CD8+ cells from ovarian cancer patients.\"},{\"question\":\"How did Kv1.3 and KCa3.1 differ between malignant and other groups?\",\"answer\":\"Kv1.3 expression was higher in patients with malignant tumors than in control or benign groups, while KCa3.1 activity was lower in the malignant tumor group compared with the others.\"}]","Activity of Potassium Channels in CD8+ T Lymphocytes: Diagnostic and Prognostic Biomarker in Ovarian Cancer? | PDF",1790007128]